Cargando…
SAT-331 Elucidating the Role of Breast Cancer Specific GATA3 Mutation in Estrogen Receptor Positive Breast Cancer
Approximately 266,000 women will be newly diagnosed with invasive breast cancer in the US this year, making it the most prevalent cancer in females, resulting in a 1 in 8 lifetime risk. Many of these tumors are of the hormone receptor positive luminal subtype, with 60-80% expressing the estrogen and...
Autores principales: | Lofgren, Kristopher, Emmanuel, Natasha, Meier, David, Kenny, Paraic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552080/ http://dx.doi.org/10.1210/js.2019-SAT-331 |
Ejemplares similares
-
SAT-341 Pharmacology and Metabolism of GLL398 an Oral Selective Estrogen Receptor Degrader for Endocrine Therapy of Breast Cancer
por: Guo, Shanchun, et al.
Publicado: (2019) -
SAT-136 Hypoxia Effect on Cytokine Production by Breast Cancer Cells
por: Avtanski, Dimiter, et al.
Publicado: (2020) -
SAT-130 The Intermediate Prolactin Receptor Is a Breast Cancer Oncogene
por: Grible, Jacqueline M, et al.
Publicado: (2020) -
SAT-137 The Effect of Hypertriglyceridemia on Triple Negative Breast Cancer Progression
por: Scully, Tiffany, et al.
Publicado: (2020) -
SAT-334 Proinflammatory Cytokines Modulate Resistin Expression in Breast Cancer Cells
por: Avtanski, Dimiter, et al.
Publicado: (2019)